Immune Cells Derived from Stem Cells May Reverse Age-Related Brain Changes and Alzheimer’s Signs

New research shows that youthful immune cells derived from stem cells can reverse signs of brain aging and improve memory in mouse models, promising potential therapies for neurodegenerative diseases.
Researchers at Cedars-Sinai Medical Center have discovered that 'young' immune cells, generated from human stem cells, can reverse signs of aging and neurodegeneration in the brains of laboratory mice. Published in the journal Advanced Science, this preclinical study highlights the potential of harnessing immune cell therapy to combat cognitive decline associated with aging and Alzheimer's disease.
The study focused on mononuclear phagocytes—immune cells responsible for clearing harmful substances from the body, which typically decline in effectiveness with age. Scientists used pluripotent stem cells, which are adult cells reverted to an early embryonic state, to produce youthful versions of these immune cells. When infused into aging mice or models of Alzheimer’s, these cells produced notable improvements.
Mice treated with these young immune cells demonstrated better memory performance in behavioral tests and showed increased numbers of mossy cells in the hippocampus—a critical region for learning and memory. Additionally, the microglia, which act as the brain’s resident immune cells, remained healthier with more extensive branching, indicating preserved function.
Interestingly, the young immune cells did not appear to directly enter the brain, suggesting their beneficial effects might be mediated through indirect mechanisms, such as releasing protective proteins or extracellular vesicles into the bloodstream that influence brain health.
This research opens the door for developing personalized immune cell therapies from stem cells, offering an unlimited source of treatment candidates. The findings suggest that short-term interventions with these cells could significantly improve cognition and neural health, paving the way for future clinical trials in humans.
The study's authors believe that such therapies could provide promising new strategies for addressing age-related cognitive decline and neurodegenerative diseases like Alzheimer’s, by restoring immune function and brain health.
For more details, see the original publication in Advanced Science: DOI: 10.1002/advs.202417848.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
New Insights into DNA Regions and Genes Driving Liver Regeneration
A recent study maps DNA regions and regulatory genes vital for liver regeneration, providing insights that could pave the way for regenerative medicine advances. Source: https://medicalxpress.com/news/2025-06-dna-regions-key-genes-liver.html
Disparities in Kidney Transplant Access for Indigenous Australians on Dialysis
Indigenous Australians on dialysis face significant barriers to kidney transplantation, with systemic issues limiting their access to life-saving treatment. Recent Australian research highlights urgent need for targeted reforms to address these disparities.
Innovative Photoacoustic Contrast Agent Enhances Tumor Imaging Safety and Cost-Effectiveness
A new biocompatible contrast agent for photoacoustic tomography offers an safer and cost-effective alternative for tumor imaging, reducing reliance on expensive and radiation-based techniques like PET.
Discovery of Salt Gully Virus in Australian Bats Enhances Preparedness Against Emerging Infectious Diseases
Scientists at CSIRO have discovered the Salt Gully virus in Australian bats, enhancing disease preparedness and understanding of henipaviruses potentially impacting human and animal health.



